PERY, BIEL, PennyOmega.com Watch List ! for Friday August 28, 2009, Perry Ellis International Inc. and BioElectronics Corp, BIEL.PK
PERY, Perry Ellis International Inc.
BIEL, BioElectronics Corp, BIEL.PK
PennyOmega.com Watch List!
PennyOmega.com Watch List ! for Friday August 28, 2009
Our Picks at PennyOmega.com for Friday August 28, 2009 are:
**************************************************************
PERY, Perry Ellis International Inc.
PERY is a leading designer, distributor and licensor of a broad line of high quality men’s, women’s and children’s apparel, accessories, and fragrances.
PERY through its wholly owned subsidiaries, owns or licenses a portfolio of brands that includes 29 of the leading names in fashion such as Perry Ellis®, Perry Ellis America®, Perry Ellis Portfolio®, Jantzen®, Laundry by Shelli Segal®, C&C California®, Cubavera®, Munsingwear®, Savane®, Farah®, Original Penguin® by Munsingwear®, Grand Slam®, Natural Issue®, Pro Player®, the Havanera Co.®, Axis®, Axist®, Manhattan®, John Henry®, Tricots St. Raphael®, Mondo di Marco®, Redsand®, Gotcha®, and MCD®. We enhance our roster of brands by licensing trademarks from third parties including Nike® and Jag® for swimwear, and Callaway® and PGA TOUR® for golf apparel.
**PERY has signed a licensing agreement with S.A.R.L. de Gestion Pierre Cardin to source, sell and distribute the Pierre Cardin® brand for men’s sportswear, except for woven shirts, in the U.S., Puerto Rico and the U.S. Virgin Islands. This is a five year agreement, starting in 2010. Perry Ellis International will distribute the brand in department stores starting next January.
More about PERY at www.pery.com
**************************************************************
BIEL, BioElectronics Corp, BIEL.PK
BIEL is the maker of inexpensive, drug–free, anti-inflammatory medical devices and patches.
BIEL’s wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch™ and RecoveryRx™.
**The dermal patch delivery system creates a multitude of new product opportunities for chronic and acute inflammatory conditions. The market potential is estimated at $10 billion or 400 million incidents worldwide. The distinctive value proposition of ActiPatch is the delivery of drug-free therapy that reduces pain and inflammation and accelerates healing by 30% to 50% when compared with the present standard methods of patient care.
Heel and foot pain, and plantar fasciitis are common conditions affecting tens of millions of people all over the world. It has been reported that plantar fasciitis occurs in 2 million Americans a year and 10% of the population over a lifetime(1). It is commonly associated with long periods of work related weight-bearing, and is especially prevalent in non-athletic populations with a high body mass index.
BIEL announced the completion of an important clinical study on heel and foot pain. BIEL study indicates that ActiPatch’s effectiveness, ease-of-use and low cost make it a viable option for the tens of millions of people who suffer from heel and foot pain, including plantar fasciitis (study participants were able to meaningfully reduce their use of pain medication).
BIEL is Preparing FDA 510(K) Pre-Marketing Notification for OTC Clearance.
More about BIEL at www.BioElectronicsCorp.com
**************************************************************
PERY and BIEL are on PennyOmega.com’s RADAR! Do your Homework, and like always BE READY for the Action!!!
**************************************************************
**************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) . Rule 17B requires disclosure of payment for investor relations.
Tags: BIEL, BIEL.PK, BioElectronics Corp, Perry Ellis, PERY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
